The nation’s healthcare system -- and with it, the laboratory community – is undergoing a period of tremendous change as The Affordable Care Act begins implementation and new healthcare delivery models such as The Patient-Centered Medical Home (PCMH) and Accountable Care Organizations (ACOs) proliferate.
COLA Inc., based in Columbia, MD, an independent, nonprofit laboratory CLIA-accreditation organization, accrediting more than 7,000 clinical diagnostic labs on July, 2013, launched a new education subsidiary, COLA Resources Inc. (CRI®), whose mission is to “Provide educational & consultative services aimed at improving laboratory medicine and patient care.”
As a leading educator in laboratory medicine, COLA Resources Inc.’s (CRI®) goal is to continually update our education platform to reflect and support education regarding changes in regulatory requirements.
Attending the CRI® Symposium for Clinical Laboratories, affords participants the opportunity to participate in discussions centered on EDUCATION FOR LABORATORY EXCELLENCE – making a positive impact for quality patient care. This year’s symposium will be held October 15-18, 2014 at the Buena Vista Palace Hotel & Spa Lake Buena Vista (Orlando), FL. Participants can attend a wide selection of educational sessions, earn up to 20 CME or P.A.C.E® credits, network with other healthcare professionals and visit the exhibit hall featuring the latest laboratory technology, equipment and supplies.
The DRG 25-OH Vitamin D (total) ELISA, an enzyme immunoassay for the measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in both serum and plasma, will be a highlight of the 2014 American Association for Clinical Chemistry (AACC) Conference.
DRG International’s Renin (Active) ELISA for testing of active Renin in human EDTA plasma will be on display at the AACC’s 2014 show in Chicago, IL on July 27-31.
As a leading manufacturer of raw material for IVD industry, Fapon Biotech Inc. discovers, develops and provides innovative antigen, antibodies and enzymes that deliver significant benefits to IVD industry.
University Hospitals (UH) Case Medical Center has signed an agreement with ARUP Laboratories, a major national clinical reference laboratory which will include in its menu of tests an HIV diagnostic test invented at the UH Translational Laboratory by Miguel Quinones-Mateu, PhD.
An article in the London Times reviews the brain function beverage market, consumer demand, the leading drinks and their ingredients.
As a global first, a new platform, www.medicinno.com, aims to bring together doctors and pharmacists to share their professional opinions and expertise, as well as stay abreast of the latest developments in the health sciences.
The Intelligent Healthcare Association (IHA), in a partnership with ASHP (American Society of Health-System Pharmacists), is excited to introduce the first-ever Intelligent Pharmacy Pavilion (IPP) at ASHP’s 2014 Midyear Clinical Meeting and Exhibition in Anaheim, CA, December 7-11.
The thyroid calculator for rapid calculation of: Calcitonin and Carcinoembryonic Antigen Doubling Time; Thyroid Nodule Volume change; Thyroid Cancer Staging. Calculation results are not preserved within the app, thus maintaining patient privacy and security.
AdhereTech and The University of Alabama in Huntsville (UAH) have been awarded a second U.S. patent for a smart pill bottle invented at UAH that automatically measures if patients have taken their medication.
The American Academy of Dermatology (Academy) is pleased to announce Bristol-Myers Squibb’s donation of its Melanoma Exposed™ program to the Academy. The donation, provided through a charitable grant, will be used to increase public awareness of skin cancer – including melanoma, the deadliest form of skin cancer – and expand the number of free skin cancer screenings across the country through the Academy’s SPOT Skin Cancer™ initiative. Bristol-Myers Squibb’s donation of Melanoma Exposed™ includes a five-year contribution to the Academy, totaling more than $4 million.
The Uniform Application makes it easier for physicians to become licensed in multiple states by providing a “core” application used by the 23 state medical boards using the UA. It eliminates the need for physicians to re-enter data multiple times and makes it easier for physicians to apply for licensure in multiple states.
The Office of the Vice President for Research at Wayne State University announced today the finalization of a license agreement with a new start-up company, Detroit Materials, Inc., for a Wayne State University patented portfolio of high-strength low-alloy steels and cast irons for demanding applications in the defense, off-highway, tooling and automotive industries.
DaVinci Biosciences, LLC announced today that their paper on "Human Prenatal Intestine Cells as a Valuable Source of Stem Cells and Epithelial Cells; Phenotypic and Functional Characterization" has been accepted for publication in the peer-reviewed journal CELL & TISSUE TRANSPLANTATION & THERAPY.
Protea Biosciences Group, Inc. (OTCQB:PRGB) announced it has entered into a research collaboration with the University of Southampton, a leading biomedical and clinical research institution located in the United Kingdom. The collaboration will partner Protea’s proprietary direct molecular imaging technology and capabilities with a team of Alzheimer’s researchers at the University of Southampton, to study the molecular mechanisms of the aged brain, in order to identify markers that may indicate risk of developing Alzheimer’s disease.
Amway has extended its exclusive research partnership with Yale University through 2016, adding an additional three years to the original agreement. Doubling the length of this collaboration enables Amway scientists and Yale Lab Associate and Research Faculty Member Dr. John Pawelek to continue advancing their collective understanding of the molecular biology involved in skin pigmentation – specifically hyperpigmented spots. Understanding the pathways involved enables the development of more effective, more targeted treatments. Findings will fuel breakthrough products in the Artistry Ideal Radiance™ Collection targeting skin brightening.
A decades-long partnership between Sandia National Laboratories and the Norwegian research organization SINTEF (Stiftelsen for industriell og teknisk forskning) will now tackle energy challenges such as renewable energy integration, electric grid modernization, gas technologies and algae-based biofuels, under an expanded agreement.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right